Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma

S. Bringhen, M. D'Agostino, L. De Paoli, V. Montefusco, A.M. Liberati, P. Galieni, S. Grammatico, V.E. Muccio, F. Esma, C. De Angelis, P. Musto, S. Ballanti, M. Offidani, M.T. Petrucci, G. Gaidano, P. Corradini, A. Palumbo, P. Sonneveld, M. Boccadoro

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)979-985
Number of pages7
Issue number4
Publication statusPublished - 2018

Cite this